Pfizer, BioNTech launch Covid-19 vaccine trial in kids under 12
Pfizer Inc and German partner BioNTech SE began testing their Covid-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the U.S. drugmaker said on Thursday.
Read more